Left ventricular dysfunction Treatment Market Size, Epidemiology, Drugs Pipeline, Market Analysis and Companies by DelveInsight

Posted on
by

Left ventricular dysfunction Treatment Market Size, Epidemiology, Drugs Pipeline, Market Analysis and Companies by DelveInsight
Left ventricular dysfunction Treatment Market

Left ventricular dysfunction refers to the condition characterized by dilation of the left ventricle of the heart. It is also associated with the narrowing of blood vessels. The main function of the left ventricle is to pump the oxygen-rich blood to all body parts.

 

DelveInsight’s “Left Ventricular Dysfunction Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Left Ventricular Dysfunction, historical and forecasted epidemiology as well as the Left Ventricular Dysfunction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Left ventricular dysfunction Market:

  • As per the study conducted by Innocenti et al. (2020), right ventricular (RV) systolic dysfunction (RVSD) was found in 85 patients (34%), was isolated in 29% (25/85), and coexisted with LVSD in 71% (60/85) patients. Left ventricular systolic dysfunction (LVSD) was present in 63% of patients (159/252) and was isolated in 99 patients.
  • According to a study by Chahine and Alvey (2021), LV failure can further subdivide into heart failure with preserved ejection fraction (HFpEF with EF over 50%), heart failure with reduced ejection fraction (HFrEF with EF less than 40%), or heart failure with mid-range ejection fraction (EF between 41 and 49%).
  • Redfield et al. (2003) conducted a study wherein overall, 20.8% of the population had mild diastolic dysfunction, 6.6% had moderate diastolic dysfunction, and 0.7% had severe diastolic dysfunction, with 5.6% of the population having moderate or severe diastolic dysfunction with normal EF. The prevalence of any systolic dysfunction (EF ≤50%) was 6.0%, with moderate or severe systolic dysfunction (EF ≤40%) being present in 2.0%.
  • According to a study conducted by Kuznetsova et al. (2009), the overall prevalence of LV diastolic dysfunction in a random sample of a general population, as estimated from echocardiographic measurements, was as high as 27.3%.

 

Request for Sample Report: https://www.delveinsight.com/sample-request/left-ventricular-dysfunction-market

 

Scope of Left ventricular dysfunction Market Report are:

  • The report covers the descriptive overview of Left Ventricular Dysfunction, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Left Ventricular Dysfunction epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Left Ventricular Dysfunction are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Left Ventricular Dysfunction market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Left Ventricular Dysfunction market

 

Download Sample Report: https://www.delveinsight.com/sample-request/left-ventricular-dysfunction-market

 

Some of Left ventricular dysfunction Companies are:

  • Bayer
  • Quantum Genomics
  • And Many Others

 

Left ventricular dysfunction Therapies are:

  • Riociguat (Adempas, BAY63-2521)
  • Firibastat
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/left-ventricular-dysfunction-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Left Ventricular Dysfunction

3. Competitive Intelligence Analysis for Left Ventricular Dysfunction

4. Left Ventricular Dysfunction: Market Overview at a Glance

4.1. Left Ventricular Dysfunction Total Market Share (%) Distribution in 2017

4.2. Left Ventricular Dysfunction Total Market Share (%) Distribution in 2030

5. Left Ventricular Dysfunction: Disease Background and Overview

6. Patient Journey

7. Left Ventricular Dysfunction Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Left Ventricular Dysfunction Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Left Ventricular Dysfunction: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Left Ventricular Dysfunction

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/left-ventricular-dysfunction-market